{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:02:21Z","timestamp":1792252941192,"version":"4.4.0"},"reference-count":15,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Palliat Care"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0973-1075.138402","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T04:42:05Z","timestamp":1407472925000},"page":"239","source":"Crossref","is-referenced-by-count":2,"title":["Metastatic primary duodenal adeno-carcinoma responding to metronomic oral cyclophosphamide chemotherapy"],"prefix":"10.25259","volume":"20","author":[{"given":"Anis","family":"Bandyopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mou","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SubhraKanti","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0973-1075.138402-1","first-page":"518","volume-title":"Adenocarcinoma of the small bowel: Presentation, prognostic factors, and outcome of 217 patients","author":"Dabaja","year":"2004","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1075.138402-2","first-page":"203","volume-title":"Malignant tumors of the small intestine: A histopathologic study of 41 cases among 1,312 consecutive specimens of small intestine","author":"Terada","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"key-10.4103\/0973-1075.138402-3","first-page":"779","volume-title":"Primary duodenal adenocarcinoma","author":"Solej","year":"2008","journal-title":"Tumori"},{"key":"key-10.4103\/0973-1075.138402-4","first-page":"111","volume-title":"Survival predictors of patients with primary duodenal adenocarcinoma","author":"Kawahira","year":"2011","journal-title":"Int Surg"},{"key":"key-10.4103\/0973-1075.138402-5","first-page":"40","volume-title":"Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?","author":"Penel","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"key-10.4103\/0973-1075.138402-6","first-page":"2038","volume-title":"Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma","author":"Overman","year":"2008","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1075.138402-7","first-page":"132","volume-title":"Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma","author":"Gibson","year":"2005","journal-title":"Oncologist"},{"key":"key-10.4103\/0973-1075.138402-8","first-page":"93","volume-title":"Metronomic chemotherapy: An antiangiogenic scheduling","author":"Laquente","year":"2007","journal-title":"Clin Transl Oncol"},{"key":"key-10.4103\/0973-1075.138402-9","first-page":"423","volume-title":"The anti-angiogenic basis of metronomic chemotherapy","author":"Kerbel","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key-10.4103\/0973-1075.138402-10","first-page":"529","volume-title":"Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma","author":"Gebbia","year":"2012","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0973-1075.138402-11","first-page":"331","volume-title":"Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: A phase II study in patients with HER2-negative metastatic breast cancer","author":"Yoshimoto","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"key-10.4103\/0973-1075.138402-12","first-page":"e195","volume-title":"Complete remission and long-term survival in a child with relapsed medulloblastoma with extensive osteosclerotic bony metastasis with a novel metronomic chemobiological approach","author":"Sondhi","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"key-10.4103\/0973-1075.138402-13","first-page":"1822","volume-title":"Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer","author":"Khan","year":"2011","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0973-1075.138402-14","first-page":"1643","volume-title":"Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma","author":"Glode","year":"2003","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1075.138402-15","first-page":"275","volume-title":"Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers","author":"Allegrini","year":"2012","journal-title":"Angiogenesis"}],"container-title":["Indian Journal of Palliative Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T06:55:22Z","timestamp":1691218522000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpalliativecare.com\/metastatic-primary-duodenal-adeno-carcinoma-responding-to-metronomic-oral-cyclophosphamide-chemotherapy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"alternative-id":["138402"],"URL":"https:\/\/doi.org\/10.4103\/0973-1075.138402","relation":{},"ISSN":["0973-1075"],"issn-type":[{"value":"0973-1075","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}